A Simple Key For Ago tumor Unveiled
Founded immune markers nevertheless maintain their relevance for medical decision-making in breast cancer treatment with even extended meanings. Estrogen receptor (ER) stage should not only be categorized in good or negative. Very low ER levels ≤ten% of labeled cells should be handled in another way (LoE 1a/A/AGO++). Tumors with minimal ER stages